Dynamics in Post-pandemic Global Pertuzumab Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ668391
Publisher: Date of Publish:
No. of Pages: 130 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Pertuzumab market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Pertuzumab market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Human Source Animal Source Segmented by End User/Segment Hospital Medical Center Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Pfizer Novartis AG InvivoGen Celltrion Bio-Techne Biocon Limited Abnova Corporation
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Pertuzumab Market Status and Forecast (2016-2027) 1.3.2 Global Pertuzumab Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global Pertuzumab Supply by Company 2.1 Global Pertuzumab Sales Volume by Company 2.2 Global Pertuzumab Sales Value by Company 2.3 Global Pertuzumab Price by Company 2.4 Pertuzumab Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional Pertuzumab Market Status by Category 3.1 Pertuzumab Category Introduction 3.1.1 Human Source 3.1.2 Animal Source 3.2 Global Pertuzumab Market by Category 3.2.1 Global Pertuzumab Sales Volume by Category (2016-2021) 3.2.2 Global Pertuzumab Sales Value by Category (2016-2021) 3.2.3 Global Pertuzumab Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category 4 Global and Regional Pertuzumab Market Status by End User/Segment 4.1 Pertuzumab Segment by End User/Segment 4.1.1 Hospital 4.1.2 Medical Center 4.2 Global Pertuzumab Market by End User/Segment 4.2.1 Global Pertuzumab Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Pertuzumab Sales Value by End User/Segment (2016-2021) 4.2.3 Global Pertuzumab Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment 5 Global Pertuzumab Market Status by Region 5.1 Global Pertuzumab Market by Region 5.1.1 Global Pertuzumab Sales Volume by Region 5.1.2 Global Pertuzumab Sales Value by Region 5.2 North America Pertuzumab Market Status 5.3 Europe Pertuzumab Market Status 5.4 Asia Pacific Pertuzumab Market Status 5.5 Central & South America Pertuzumab Market Status 5.6 Middle East & Africa Pertuzumab Market Status 6 North America Pertuzumab Market Status 6.1 North America Pertuzumab Market by Country 6.1.1 North America Pertuzumab Sales Volume by Country (2016-2021) 6.1.2 North America Pertuzumab Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe Pertuzumab Market Status 7.1 Europe Pertuzumab Market by Country 7.1.1 Europe Pertuzumab Sales Volume by Country (2016-2021) 7.1.2 Europe Pertuzumab Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific Pertuzumab Market Status 8.1 Asia Pacific Pertuzumab Market by Country 8.1.1 Asia Pacific Pertuzumab Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Pertuzumab Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America Pertuzumab Market Status 9.1 Central & South America Pertuzumab Market by Country 9.1.1 Central & South America Pertuzumab Sales Volume by Country (2016-2021) 9.1.2 Central & South America Pertuzumab Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa Pertuzumab Market Status 10.1 Middle East & Africa Pertuzumab Market by Country 10.1.1 Middle East & Africa Pertuzumab Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Pertuzumab Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Pertuzumab Manufacturing Cost Analysis 11.5 Pertuzumab Sales Channel and Distributors Analysis 11.5.1 Pertuzumab Sales Channel 11.5.2 Pertuzumab Distributors 11.6 Pertuzumab Downstream Major Buyers 12 Global Pertuzumab Market Forecast by Category and by End User/Segment 12.1 Global Pertuzumab Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Pertuzumab Forecast by Category 12.2.1 Global Pertuzumab Sales Volume Forecast by Category 12.2.2 Global Pertuzumab Sales Value Forecast by Category 12.2.3 Global Pertuzumab Price Forecast by Category 12.3 Global Pertuzumab Forecast by End User/Segment 12.3.1 Global Pertuzumab Sales Volume Forecast by End User/Segment 12.3.2 Global Pertuzumab Sales Value Forecast by End User/Segment 12.3.3 Global Pertuzumab Price Forecast by End User/Segment 13 Global Pertuzumab Market Forecast by Region/Country 13.1 Global Pertuzumab Market Forecast by Region (2022-2027) 13.1.1 Global Pertuzumab Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Pertuzumab Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Pfizer 14.1.1 Company Information 14.1.2 Pertuzumab Product Introduction 14.1.3 Pfizer Pertuzumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Novartis AG 14.2.1 Company Information 14.2.2 Pertuzumab Product Introduction 14.2.3 Novartis AG Pertuzumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 InvivoGen 14.3.1 Company Information 14.3.2 Pertuzumab Product Introduction 14.3.3 InvivoGen Pertuzumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Celltrion 14.4.1 Company Information 14.4.2 Pertuzumab Product Introduction 14.4.3 Celltrion Pertuzumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Bio-Techne 14.5.1 Company Information 14.5.2 Pertuzumab Product Introduction 14.5.3 Bio-Techne Pertuzumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Biocon Limited 14.6.1 Company Information 14.6.2 Pertuzumab Product Introduction 14.6.3 Biocon Limited Pertuzumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Abnova Corporation 14.7.1 Company Information 14.7.2 Pertuzumab Product Introduction 14.7.3 Abnova Corporation Pertuzumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis ... 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com